These top stock picks could have big third quarters.

July 12, 2021

View in Browser

U.S. News & World Report

Invested

Advice, rankings and stock market news for investors.

Good morning, investors. President Joe Biden signed a broad executive order on Friday aimed at creating a competitive market across the U.S. economy.

Today's Featured Stock Story

Bank of America's 8 Best Stocks to Buy in Q3

The liming action on the large wheat field

The stock market's huge run off March 2020 pandemic lows continued in the second quarter, sending the S&P 500 up by 14.4% in the first half to new all-time highs above 4,300.

Investors are growing increasingly optimistic that a combination of vaccine rollouts, economic reopenings and pent-up consumer demand will propel stock prices even higher in the second half.

Bank of America recently released its quarterly list of top stocks to buy for the next three months. These eight stock picks are high-conviction investment ideas that have bullish catalysts coming sometime in the third quarter:

1. Affirm Holdings (ticker: AFRM). Analyst Jason Kupferberg says buy now, pay later company Affirm's fiscal fourth-quarter earnings report and initial fiscal 2022 guidance – which are likely coming in early September – will be positive catalysts for the stock.

2. CNH Industrial (CNHI). Analyst Ross Gilardi says this global farm equipment manufacturer has several longer-term bullish catalysts, including a booming farm economy, elevated investment in precision farming, recovering end markets and its recent $2.1 billion buyout of Raven Industries.

Click here to continue.

Check out our most popular stories:
7 Bank Stocks to Buy for the Dividends
7 Best Cheap Stocks to Buy Now Under $5
10 Best ETFs to Buy for 2021

Markets

Dow

34,870 (+1.3%)

Nasdaq

14,701 (+0.98%)

S&P 500

4,369.55 (+1.13%)

* Market data as of Friday's close

Here's what you missed in the markets last week.

Investing Advice

Old fortress gate with light trails at downtown

The best emerging-market ETFs to buy. Investors face two challenges when trying to enter emerging markets: keeping fees down and finding investments that are large and liquid enough to buy and sell without complications. Many low-cost index funds are competitive on price, assets under management and trading volume. Here are seven of the best emerging-market exchange-traded funds to buy.

Caught Our Eye

U.S. President Joe Biden speaks during an announcement related to small businesses at the South Court Auditorium of the Eisenhower Executive Office Building

Investors overcome virus variant concerns. All three major U.S. stock market indexes posted strong rebounds from Thursday's sell-off, with each notching record closing highs to finish the week Friday.

Concerns over variants of the virus had worried investors earlier in the week, but Wall Street resoundingly bought the dip on Friday, and the beginning of earnings season this week will ring in a new period of evaluating growth versus expectations.

With stocks at all-time highs, the bar is set high. The Dow Jones Industrial Average jumped 448 points, or 1.3%, to finish at 34,870 on Friday.

Biden's executive order. President Joe Biden signed an executive order aimed at curbing the power of large corporations in favor of more competition from smaller businesses. The order comes as the president aims to define his administration early in his term, in part by taking a tough stance on antitrust issues – especially in Big Tech.

Stamps.com surges 64% on buyout offer. Online postage firm Stamps.com (STMP), whose services are increasingly used in the booming e-commerce industry, agreed to be taken private in a $6.6 billion offer from private equity firm Thoma Bravo.

The $330-per-share offer was a massive 67% premium to the stock’s closing price the day before. The company still has 40 days to shop itself to other potential suitors in pursuit of a higher price.

FDA requests Biogen probe. The head of the U.S. Food and Drug Administration called for a review of her own agency's approval of Biogen's (BIIB) Alzheimer’s drug Aduhelm, spurred by the FDA’s controversial decision to approve the treatment.

Acting FDA commissioner Dr. Janet Woodcock said that she wanted to ensure the agency’s interaction with Biogen was appropriate, sparking her request to the Office of the Inspector General.

BIIB stock fell 3% on Friday on the news.

- Caught Our Eye written by Henry Hilker

Explore Stock and Fund Rankings

Top Construction and Farm Machinery Stocks

CompanyPrice1 Year Return
Terex Corp.Price: $44.451 YR Return: 156.99%
AGCO Corp.Price: $125.491 YR Return: 143.65%
CNH Industrial NVPrice: $15.571 YR Return: 134.36%
Deere & Co.Price: $343.581 YR Return: 120.04%
Toro Co.Price: $110.891 YR Return: 73.53%
Oshkosh CorpPrice: $119.871 YR Return: 72.52%
Caterpillar Inc.Price: $212.111 YR Return: 71.98%
Westinghouse Air Brake Technologies CorpPrice: $80.131 YR Return: 42.42%
Cummins Inc.Price: $237.481 YR Return: 41.05%
BorgWarner IncPrice: $46.621 YR Return: 37.5%

Data as of November 16, 2026

Connect With Us

✉ If you're enjoying this newsletter, forward it to a friend! They can click here for their free daily dose of investing tips. You can also check out more U.S. News newsletters here.

❤ We'd love your feedback. Please email thoughts and suggestions to invested@usnews.com.

Jordan Kron, Investing Editor @jnkron31
John Divine, Senior Financial Markets Editor @Divinebizkid
Paulina Likos, Investing Reporter @Paulina_Likos
Susannah Snider, Senior Editor, Advisors @SusSnider

U.S. News & World Report
Unsubscribe from This Email List | Manage My Email Preferences | Privacy Policy

© 2026 U.S. News & World Report, L.P. All rights reserved.
1050 Thomas Jefferson St. NW, Washington, DC 20007 USA

USN Facebook LinkUSN Twitter Link

If you believe this has been sent to you in error, please safely unsubscribe.